BioMarin Pharmaceuticals (BMRN -1.8%) slips on a downgrade to Hold at Deutsche. The firm says...

|About: BioMarin Pharmaceutical Inc. (BMRN)|By:, SA News Editor

BioMarin Pharmaceuticals (BMRN -1.8%) slips on a downgrade to Hold at Deutsche. The firm says much of the good news is baked into the stock, and it sees no compelling risk/reward tradeoff going all the way into Q4.